Yaohai Bio-pharma provides flexible and customized analytical solutions, including phase-appropriate analytical method development and validation.
Our team has significant expertise in analytics for all stages of the biologics development lifecycle, from early-stage protocols to late-stage quality control (QC) method optimization. Tests are designed in consideration of the relevant Pharmacopoeia (EU and US monographs), regulatory guidelines (ICH, FDA, and EMEA), and GMP/GLP practices.
Our team has significant expertise in the analytics for various types of recombinant proteins or peptides, e.g., Recombinant Vaccines, VHH/Nano-Antibodies, Antibody Fragments, Hormones, Cytokines, Growth Factors (GF), Enzymes, Collagens, Fusion or Conjugated Proteins and any other microbial-based Proteins/Peptides.
Service Details
- Method Development and Optimization for in-process controls, release and stability studies
- Analytical Method Qualification/Validation
- QC and Stability Studies of research batches
- Reference standard generation and characterization
- Protein Characterization (physicochemical and structure); Comparability and Similarity Assessment
- Technology transfer to QC
Method Development and Pre-validation:
| Quality Attributes |
Analytical Methods |
Delivery Time (Working Days) |
| Total Protein Content |
UV (Ultraviolet), BCA (Bicinchoninic Acid), Bradford, Lowry |
20 |
| Target Protein Identity |
WB (Western blotting) |
20 |
| Purity, Size Variants |
SEC-HPLC (Size Exclusion Chromatography-High Performance Liquid Chromatography) |
20~40 |
| CE-SDS (Capillary Electrophoresis-Sodium Dodecyl Sulfate) |
20~40 |
| Purity, Charge Variants |
IEX-HPLC (Ion-Exchange High Performance Liquid Chromatography) |
20~40 |
| iCIEF (Imaged Capillary Isoelectric Focusing) |
20~40 |
| Purity, Hydrophobicity |
RP-HPLC (Reverse Phase High Performance Liquid Chromatography) |
20~40 |
| HIC-HPLC (Hydrophobic Interaction Chromatography-High Performance Liquid Chromatography) |
20~40 |
| Peptide Mapping |
HPLC (High Performance Liquid Chromatography) |
20~40 |
| MS Peptide Mapping |
LC-MS (Liquid Chromatography-Mass Spectrometry) |
20~40 |
| Isoelectric Point (pI) |
cIEF (Capillary Isoelectric Focusing) |
20~40 |
| Host Cell Protein (HCP) |
ELISA (Enzyme-Linked Immunosorbent Assay) |
20~40 |
| Host Cell DNA (HCD) |
qPCR (Quantitative Polymerase Chain Reaction) |
20~40 |
| Residual RNA |
qPCR |
20~40 |
| Residual Antibiotics |
ELISA |
20~40 |
| Residual IPTG |
HPLC |
20~40 |
| Residual Defoamers |
HPLC |
20~40 |
| Residual Triton X-100 |
HPLC |
20~40 |
| PEG Content |
HPLC |
20~40 |
| Residual Tween-20/ Tween-80 |
HPLC |
20~40 |
| Other Product/Process Related Impurities |
HPLC, ELISA, etc. |
To Be Determined (TBD) |
Related Services
Protein Structure Characterization
Quality Control (QC) and Stability Studies
IW
EN
AR
HR
CS
DA
NL
FI
FR
DE
EL
IT
JA
KO
NO
PL
PT
RO
RU
ES
SV
ID
LV
LT
SR
SK
SL
UK
VI
ET
HU
TH
TR
FA
AF
MS
BE
MK
UR
BN
